The evaluation of canine atopic dermatitis extent and severity index (CADESI) test in dogs with atopic dermatitis (AD) treated with cyclosporine or prednisone

• Autorzy: Taszkun I.
• Języki publikacji: EN

Abstrakty

EN

The purpose of this study was to assess the clinical state of dogs with atopic dermatitis (AD) by use of CADESI test in own modification during the first visit in the Dermatology Consult Room as well as during the treatment. The study was performed in two groups (I-E and II-C) of 20 dogs in each group. In dogs which were qualified to the I-E group, as antiallergic, anti-inflammatory and antipruritic treatment, prednisone (oral preparation Encorton – Polfa Pabianice) at dose 0.5 mg/kg b.w./day was administered, while in dogs qualified to the II-C group – cyclosporine (oral preparation Sandimmun Neoral – Novartis Pharma) at a dose of 5 mg/kg b.w./day; the treatment was continued for 6 weeks in both groups. During the study, skin lesions were assessed in 15 specified body areas using 4 parameters and 5-point scale. In group I-E and II-C the amount of received points in CADESI test was decreased by 82.26% and by 83% respectively, after the treatment. Statistical analyses of the results obtained revealed no statistically significant (P=0.05) differences between means of I-E and II-C groups in consecutive examinations, which indicates comparable clinical efficacy of both drugs. Statistically significant differences (P=0.05) of the parameters assessed were found after secondary dermatoses treatment, and after every two weeks of antipruritic and anti-inflammatory treatment.

Słowa kluczowe

EN

canine atopic dermatitis extent and severity index test; dog; atopic dermatitis; dermatitis; treatment; prednisone; cyclosporin; animal disease

• Wydawca: -
• Czasopismo: Polish Journal of Veterinary Sciences
• Rocznik: 2010
• Tom: 13
• Numer: 4
• Opis fizyczny: p.681-688,fig.,ref.

Twórcy

autor

Taszkun I.

• Sub-department of Clinical Diagnostics and Veterinary Dermatology, Department and Clinic of Internal Medicine, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Gleboka 30, 20-612 Lublin, Poland

Bibliografia

• Burton G, Burrows A, Walker R, Robson D, Bassett R, Bryden S, Hill S (2004) Efficacy of cyclosporin in the treatment of atopic dermatitis in dogs – combined results from two veterinary dermatology referral centres. Aust Vet J, 82: 681-685
• Carlotti D, Madiot G, Ducret J, Jasmin P, Gardey L (2004) Use of recombinant omega interferon therapy in canine atopic dermatitis: a pilot study. Vet Dermatol 15: 32-28
• DeBoer DJ, Hiller A (2001) The ACVD task force on canine atopic dermatitis (XV): Fundamental concepts in clinical diagnosis. Vet Immunol Immunopathol 81: 271-276
• Favrot C, Linek M, Mueller R, Zini E, International Task Force on Canine Atopic Dermatitis (2010) Development of a questionnaire to assess the impact of atopic dermatitis on health-related quality of life of affected dogs and their owners. Vet Dermatol 21: 63-69
• Favrot C, Steffan J, Seewald W, Picco F (2010) A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis. Vet Dermatol 21: 23-31
• Germain PA, Prelaud P, Bensignor E (2005) CADESI (Canine Atopic Dermatitis Extent and Severity Index) reproducibility. Rev Med Vet-Toulouse 156: 382-385
• Gliński W, Kruszewski J, Silny W, Kurzawa R, Czarnecka-Operacz M, Baran E, Szepietowski J (2004) Diagnostic prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force on the national specialists on dermatology and venereology and allergology. Postep Derm Alergol 21: 265-277
• Kunz B, Oranje AP, Labre´ze L., Stalder JF, Ring J, Taieb A (1997) Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 195: 10-19
• Marsella R, Olivry T, Nicklin C, Lopez J (2006) Pilot investigation of a model for canine atopic dermatitis: environmental house dust mite challenge of high-IgE-producing beagles, mite hypersensitive dogs with atopic dermatitis and normal dogs. Vet Dermatol 17: 24-35
• Nesbitt GH (1978) Canine allergic inhalant dermatitis: a review of 230 cases. J Am Vet Med Assoc 172: 55-60
• Nesbitt GH, Kedan GS, Cacciolo P (1984) Canine atopy.1. Etiology and diagnosis. Compendium on Continuing Education of Practicing Veterinarian 6: 73-84
• Olivry T, Guague´re E, Heripret D (1997) Treatment of canine atopic dermatitis with misoprostol, a prostaglandin E1 analogue: an open study. J Dermatol Treat 8: 243-247
• Olivry T (2001) The American Collage of Veterinary Dermatology Task Force on Canine Atopic Dermatitis. Special Issue. Elsevier Science BV
• Olivry T, Rivierre C, Jackson HA, Murphy MK, Davidson G, Sousa CA (2002) Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial. Vet Dermatol 13: 77-87
• Olivry T, Mueller RS, International Task Force on Canine Atopic Dermatitis (2003) Evidence-based veterinary dermatology : a systematic review of pharmacotherapy of canine atopic dermatitis. Vet Dermatol 14: 121-146
• Olivry T, Marsella R, Iwasaki T, Mueller RS, International Task Force on Canine Atopic Dermatitis (2007) Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis. Vet Dermatol 18: 78-86
• Olivry T, Mueller R, Nuttall T, Favrot C, Prelaud P, International Task Force on Canine Atopic Dermatitis (2008) Determination of CADESI-03 thresholds for increasing severity levels of canine atopic dermatitis. Vet Dermatol 19: 115-119
• Prelaud P, Guague´re E, Alhaidari Z, Faivre N, Heripret D (1998) Reevaluation of diagnostic criteria of canine atopic dermatitis. Rev Med Vet-Toulouse 149: 1057-64
• Reedy L M., Miller WH., Willemse JRT (1997) Allergic skin diseases of dogs and cats. 2nd ed, WB Saunders Comp. Ltd, Philadelphia
• Scott D, Miller W, Griffin C (2001) Muller and Kirk’s Small Animal Dermatology, 6th ed, WB Saunders Comp., Philadelphia
• Steffan J, Alexander D, Brovedani F, Fisch RD (2003) Comparison of cyclosporine A with methylprednisolone for treatment of canine atopic dermatitis: a parallel blinded, randomized controlled trial. Vet Dermatol 14: 11-22
• Steffan J, Horn J, Gruet P, Strehlau G, Fondati A, Ferrer L, Noli C (2004) Remission of the clinical signs of atopic dermatitis in dogs after cessation of treatment with cyclosporin A or methylprednisolone. Vet Rec 154: 681-684
• Willemse A (1984) Investigation of symptomatology and the significance of immediate skin test reactivity in canine atopic dermatitis. Res Vet Sci 34: 261-266
• Willemse A (1986) Atopic skin disease: a review and a reconsideration of diagnostic criteria. J Small Anim Pract 27: 771-778